Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001465652-18-000005
Filing Date
2018-04-19
Accepted
2018-04-19 14:09:56
Documents
1
Period of Report
2018-04-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3823
  Complete submission text file 0001465652-18-000005.txt   5309
Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 407-271-8516
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address
RODINO III PETER W. (Reporting) CIK: 0001583701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-27072 | Film No.: 18763317